Our objective is to present recent research findings on recalcitrant chronic rhinosinusitis (CRS) in relation to "Severe Chronic Upper Airway Disease" (SCUAD).
Introduction
Severe Chronic Upper Airway Disease (SCUAD) is a term recently introduced by Bousquet et al. (1) defining those patients with allergic (AR), non-allergic (NAR), and occupational rhinitis (OR) and chronic rhinosinusitis (CRS) with and without nasal polyposis, whose symptoms are inadequately controlled despite pharmacological treatment following international validated guidelines, such as ARIA (2, 3) and EPOS2012 (4) . Chronic inflammatory disorders of the upper airways are extremely prevalent and have a major impact on public health and the socioeconomic state (2, 3) .
It is estimated that up to one third of rhinitis and rhinosinusitis patients present with persistent inflammation and/or symptoms despite adequate treatment (3, 4) . In other words, a great number of these patients fail to respond to treatment options suggested by guidelines such as antibiotics, steroids or surgery. Moreover, these disorders commonly complicate diagnosis and management of diseases of the lower airways. The group of SCUAD patients is a subgroup of patients that challenge the currently available treatment schemes and stress the importance of research in the field of difficult to treat rhinitis and rhinosinsusitis patients.
Although rhinitis is not a life-threatening disease, patients with this condition and especially those with SCUAD have a severely impaired quality of life (5) . Moreover, patients with CRS have more bodily pain and worse social functioning than patients with chronic obstructive pulmonary disease (COPD), congestive heart failure, or back pain (6) . CRS represents a significant health problem, resulting in frequent surgical procedures and a large financial burden on society (4) . Despite recent clinical and basic research efforts, the pathophysiology of the disease is only beginning to be understood. Current research has reinforced the belief that CRS is a multifactorial disease process involving genetic, environmental, occupational, anatomic, iatrogenic and immunological factors (7) . Based on the concept of "united airways", new diagnostic and therapeutic approaches are required to delineate whether intermittent and persistent inflammatory disorders of the upper airways represent a common disease with strong relationships with asthma and other diseases, or are distinct entities that interact with each other or are simply being confused because of common symptoms ( Figure 1 ). The scope of this review is to highlight the arguments and evidence on each of the aforementioned hypotheses and how these relate to SCUAD, to reinforce clinical and basic research towards a better delineation of these issues.
SCUAD

Definition issues
Attempts have been made to define rhinosinusitis in terms of pathophysiology, microbiology, radiology, severity and duration of symptoms (8) (9) (10) . However, the predictive value of the symptom-based definition of CRS, commonly used in epidemiological studies, falls behind that which includes objective tests (11) . The EP3OS document (4) offers definitions for clinical and research use, as well as for epidemiological studies. Despite the initial results showing that symptom-based CRS is significantly associated with positive endoscopy and with self-reported doctordiagnosed CRS (12) , further adjustments are needed because they have a moderate reliability over time (12) . Moreover, a more recent study (13) questioned whether these definitions evaluate the same disease due to their moderate agreement.
In addition, signs and symptoms of allergic and non allergic rhinitis overlap. These entities are routinely differentiated by the presence or absence of an overt IgE-mediated pathogenic mechanism, however local IgE may be relevant (14) .
Related etiological factors
Despite previous studies suggesting that there is an increased incidence of acute and chronic rhinosinusitis in patients with allergic rhinitis (15) (16) (17) more recent evidence suggests that allergic rhinitis is an associated condition rather that a trigger for CRS (18) . Several mechanisms have been studied regarding the pathophysiology of rhinosinusitis in association to allergic and non-allergic rhinitis, such as the role of mucociliary clearance.
However, the role of sinonasal cilia, their response to environmental stimuli and their function under several conditions remains unclear (19, 20) . For example, cystic fibrosis (CF) and primary ciliary dyskinisia (PCD) both cause disturbances of mucociliary clearance and are commonly implicated in difficult-to-treat CRS cases. Nevertheless, CF, unlike PCD (21) , often presents as CRS with nasal polyps and is associated with infection and biofilms, indicating the existence of complex molecular and biochemical mechanisms that are incompletely understood. The current development of nasal and lung biomarkers, such as nitric oxide (22) , for the differential diagnosis of those diseases signifies the importance of further basic and translational research studies.
The reverse interaction, namely the impact of microbial colonization and/or environmental agents on allergic and non-allergic rhinitis, remains incompletely understood. Microbial infections and bacterial products, such as Staphylococcus aureus enterotoxin B have been implicated in inflammatory responses (23) , and have been shown to facilitate allergic sensitization (24) . However, the complexity of the issue can be seen by the studies on the hygiene hypothesis (25) shown to be upregulated in response to repeated microbial insults (26) . TLRs are implicated in the hygiene hypothesis and several experimental (with TLR agonists), genetic (mostly in relations to TLR polymorphisms) and epigenetic data are now available. However, information gathered on the issue is insufficient for robust verification of the vicious cycle theory reported in Figure 1 . In other words, unless the complexity of the molecular interactions between assaulting factors and immunological host responses as well as their biochemical consequences is resolved, the hypothesis that Severe Chronic Upper Airway Diseases are caused by a dysfunction of the feedback mechanism in some patients, cannot be supported.
A single disease?
Multiple pathophysiological pathways involving innate and adaptive immune responses, specific cytokine profiles, molecular mechanisms at the level of epithelial cells, surface, microenvironment or intracellular matrix have been found in common in allergic and non-allergic rhinitis and CRS. A hypothesis that can be generated is that the minority of patients with allergic rhinitis, non-allergic rhinitis and CRS, who have symptoms refractory to standard medical therapy and sinus surgery procedures, may have a common underlying pathophysiological condition that presents as Severe Chronic Upper Airway Disease.
The "united airways concept" (Figure 2 ) implies that besides the anatomical continuity of the upper and lower airways, inflammation in one part of the airway influences the homeostasis of the other (27) . The mechanisms underlying this interaction have been studied primarily in allergic disease, showing systemic immune activation, induction of inflammation at a distance, and a negative impact of nasal inflammation on bronchial homeostasis (27) . In addition to allergy, the concept of global airway disease has been demonstrated among others in patients with nonallergic asthma and in those with COPD who present with sinonasal symptoms and inflammatory markers in nasal lavages (28) .
To further expand the idea of a broader causal mechanism the term allergic rhinosinusitis has been adopted by some authors (29) . Several hypotheses have been vigorously debated during the past decade with the majority of studies implicating fungi, biofilms and superantigens in the pathogenesis of CRS. Several of them have been influenced by analogous studies on asthma.
A T-cell-driven, non-IgE-mediated hypersensitivity response that culminates in the attraction and specific targeting of eosinophils against colonized fungi in the nasal lumen of CRS patients, with subsequent degranulation and mucosal damage, has been proposed as a possible mechanism of CRS (30). This hypothesis, the so-called fungal hypothesis, which strongly relates allergic rhinitis, non-allergic rhinitis and CRS, suggests that high levels of Alternaria trigger the accumulation of peripheral blood mononuclear cells and eosinophils. Still, evidence is lacking if this is a disease-specific response or whether Alternaria has any relevance to the establishment of CRS (31) . Moreover, new culture techniques revealed that the percentage of positive fungi cultures was the same in normal controls and in CRS patients (32) . Finally, later clinical studies examining the effect of topical antifungal agents were disappointing (33, 34) .
Immune responses are being implicated also in the superantigen (SAg) hypothesis, which incorporates biofilm formation and toxin secretion mainly by S. aureus. The biofilm has been described as an aggregation of microorganisms embedded in a protective self-produced polysaccharide matrix. According to the superantigen hypothesis, S. aureus protected by biofilms or sequestered within epithelial cells secrete toxins that result in a generalized stimulation of T cells, cytokine release, and a local polyclonal IgE response, all of which stimulate eosinophil recruitment and the clinical and histopathological changes associated with polypoid CRS (31) . Although about half of CRS with nasal polyposis patients show evidence of Streptococcal Ag responses, multiple pathophysiological pathways likely exist for the development of CRS. This is an evolving field of knowledge and even the role of biofilms is being disputed lately by researchers who believe that the biofilm in the nose and paranasal sinuses is "nothing else but regular respiratory mucosal blanket, a part of the mucociliary system itself, and containing variable number of bacteria" (35) . In terms of therapeutic implications, further research is required to clarify whether prophylactic anti- response. The Th2-biased mucosal inflammation, in turn, favours the programming of M2 macrophages within the polyp tissue in CRS with nasal polyps (40) and may contribute to polyps formation. This process can be further violated by a deficiency in T regulatory cells or deregulation in cytokines production, like IL-2 or IL-5, attributed to several genetic and epigenetic factors.
Overwhelming data have also been published on the epithelial expression of cytokines that regulate Th2 cytokine responses (i.e., thymic stromal lymphopoietin, IL-25, and IL-33). To further complicate the issue, multiple pathways are involved in the interaction between T cells and other immune cells, like eosinophiles, dentritic cells and baseophils, seen in rhinitis patients (i.e. CRTH2 antagonism is currently being studied as a new therapeutic approach for allergic patients (41, 42) ). An example of the complex inflammatory response in allergic rhinitis is reviewed in (43) . In SCUAD, however, chronic, constant and serious inflammation leads to alternation of expression and concentration of cytokines, ligands, receptors, etc, that obscure the primary deficiency.
In contrary to SCUAD patients, the majority of CRS, allergic and non-allergic rhinitis cases, that are relatively easily treated, have known extrinsic and intrinsic factors and current therapeutic regimens (i.e. antibiotics, immunotherapy) "alleviate" immune responses. After the exclusion of incorrect diagnoses and specific causes of difficult to treat CRS cases (reviewed in (44) and (45) ), such as odontogenic inflammation, a significant percentage of patients is reported as having SCUAD (44) . It is of interest that an alternation of cytokines production by epithelial and immune cells, as those reported very briefly in the above paragraphs, can cause a failure of the regulation of Th1 and Th2 responses. Our hypothesis, depicted in Figure 4 , is that apart from extrinsic and intrinsic factors that can contribute to a constant inflammation characterized either by Th1 or Th2 predominance, defective pathways involved in Th1 vs Th2 response regulation may be the single or just a simple cause of SCUAD. Antigen passage and processing across the nasal epithelium is promoted by defects of the mechanical and innate immune protective barrier that leads to the generation of the chronic inflammatory infiltrate observed in CRS (31) . As proposed by Kern et al. (31) , "variations in the expression of genes that govern critical host epithelial pathways may increase the susceptibility to CRS.
Unmet needs and future research directions
Environmental factors, rather than discrete etiological agents, can be seen as disease modifiers that skew the clinical presentation in an individual patient. " However, this has been criticized as being over simplistic (9) (37, 38) .
SCUAD immunopathology
The not well delineated pathophysiological mechanism of recalcitrant CRS has lead as to propose a symptom-based treatment algorithm (39) . However, optimal treatment cannot be based on partial symptoms control. The question whether SCUAD represents a single disease is a result of a disrupted feedback mechanism in patients with CRS, allergic or non allergic rhinitis, or is just the clinical presentation of different entities reflects our lack of understanding of the pathophysiology at cellular and molecular levels. tory mediators (eg, IL-5) are still unknown (28) . To design novel treatments, a better understanding of disease mechanisms is needed.
Researchers work towards identifying key genetic polymorphisms and epigenetic variations and how they promote disease susceptibility in the individual patient (31, 48) . A better understanding of the local features of the chronically inflamed epithelium will be essential for the developing of new diagnostic and therapeutic tools. It is intriguing that roots of modern topical treatments can be found in early knowledge of rhinological disease, as presented in texts of antiquity (49) . Targeting therapies to intervene in the particular defective pathway(s) present may be preferable to broad suppression of inflammation or extensive efforts to reduce microbial colonization with antibiotics (31) and are expected to be a breakthrough of current evolution of molecular biology. SCUAD is not a lethal disease, thus new regimens that are related to immune function and especially to T cells interactions, are expected to be utilized in other more serious diseases first, as it has already done with IgE, IL-5 and CRTH2 antagonists. Nevertheless, the concept of SCUAD will allow clinical and molecular research efforts to be directed towards difficult and treatmentunresponsive CRS.
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There was no conflict of interest in this study. explicit definition of control of disease is required. The concept of control of disease has only recently been introduced in the field of AR and CRS (44) . As it has already been mentioned in the section of the SCUAD pathophysiology, in case of poor control of symptoms despite guideline-directed pharmacotherapy, one needs to consider the presence of SCUAD but also treatmentrelated, diagnosis-related and/or patient-related factors (44) .
Furthermore, contributing factors such as exposure to environmental or occupational agents, underlying gastroesophageal reflux, and/or infection or colonization with micro-organisms need better understanding (28) . Fungal extracts and bacterial enterotoxins were linked to the etiology of nasal polyposis.
Nevertheless, only few studies have examined viral contribution to pathogenesis of the mucosal inflammation, although viruses are widely considered as a triggering factor, especially in aspirinsensitive rhinosinusitis (46, 47) . Atypical bacteria, such as Mycoplasma and Chlamydia may also hold an unidentified role (27) .
Recent mechanistic studies have revealed a complex bidirectional communication between sinonasal epithelial cells and the adaptive immune system (36) . In addition, the cellular sources as well as the mechanisms of systemic release of proinflamma- Th2 response (e.g. most cases of CRSwNP) SCUAD? Figure 4 . SCUAD can be attributed to a single primary deficiency in Th1 vs Th2 responses regulation or maybe a multifactorial disease with multiple defective pathways leading to common CRS symptoms.
